Nuclear Medicine and Biology
Volume 33, Issue 8 , Pages 963-969 , November 2006

Radioiodinated VEGF to image tumor angiogenesis in a LS180 tumor xenograft model

  • Mitsuyoshi Yoshimoto

      Affiliations

    • Division of Health Sciences, Graduate School of Medical Science, Kanazawa University, Ishikawa 920-0942, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 76 265 2539; fax: +81 76 234 4366.
    • ,
  • Seigo Kinuya

      Affiliations

    • Department of Biotracer Medicine, Graduate School of Medical Science, Kanazawa University, Ishikawa 920-8640, Japan
    • ,
  • Atsuhiro Kawashima

      Affiliations

    • Kanazawa Medical Center, Ishikawa 920-8650, Japan
    • ,
  • Ryuichi Nishii

      Affiliations

    • Department of Radiology, Fujimoto Hayasuzu Hospital, Miyazaki 885-0055, Japan
    • Biomedical Imaging Research Center, University of Fukui, Fukui 910-1193, Japan
    • ,
  • Kunihiko Yokoyama

      Affiliations

    • Department of Biotracer Medicine, Graduate School of Medical Science, Kanazawa University, Ishikawa 920-8640, Japan
    • ,
  • Keiichi Kawai

      Affiliations

    • Division of Health Sciences, Graduate School of Medical Science, Kanazawa University, Ishikawa 920-0942, Japan
    • Biomedical Imaging Research Center, University of Fukui, Fukui 910-1193, Japan

Received 28 April 2006 ,Revised 9 August 2006 ,Accepted 10 August 2006.

References 

  1. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol. 1992;3:65–71
  2. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis — correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1–8
  3. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 1993;143:401–409
  4. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 1992;13:18–32
  5. Li S, Peck-Radosavljevic M, Koller E, Koller F, Kaserer K, Kreil A, et al. Characterization of 123I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy. Int J Cancer. 2001;91:789–796
  6. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 1992;359:845–848
  7. Plate KH, Breier G, Weich HA, Mennel HD, Risau W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer. 1994;59:520–529
  8. McMahon G. VEGF receptor signaling in tumor angiogenesis. Oncologist. 2000;5(Suppl 1):3–10
  9. Los M, Voest EE. The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancer. Semin Oncol. 2001;28:93–105
  10. Cross MJ, Claesson-Welsh L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci. 2001;22:201–207
  11. Prewett M, Huber J, Li Y, Santiago A, O'Connor W, King K, et al. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res. 1999;59:5209–5218
  12. Gangjee A, Yang J, Ihnat MA, Kamat S. Antiangiogenic and antitumor agents: design, synthesis, and evaluation of novel 2-amino-4-(3-bromoanilino)-6-benzylsubstituted pyrrolo[2,3-d]pyrimidines as inhibitors of receptor tyrosine kinases. Bioorg Med Chem. 2003;11:5155–5170
  13. Furet P, Bold G, Hofmann F, Manley P, Meyer T, Altmann KH. Identification of a new chemical class of potent angiogenesis inhibitors based on conformational considerations and database searching. Bioorg Med Chem Lett. 2003;13:2967–2971
  14. Ueda Y, Yamagishi T, Samata K, Ikeya H, Hirayama N, Takashima H, et al. A novel low molecular weight antagonist of vascular endothelial growth factor receptor binding: VGA1155. Mol Cancer Ther. 2003;2:1105–1111
  15. Staudenherz A, Wolfsberger S, Killer M, Nasel C, Puig S, Marosi C, et al. Microvessel density is not crucial for scintigraphic visualization of brain tumors using 99mTc-MIBI. Microvasc Res. 2004;67:218–222
  16. Cooper ME, Vranes D, Youssef S, Stacker SA, Cox AJ, Rizkalla B, et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes. 1999;48:2229–2239
  17. Asano M, Yukita A, Suzuki H. Wide spectrum of antitumor activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor. Jpn J Cancer Res. 1999;90:93–100
  18. Collingridge DR, Carroll VA, Glaser M, Aboagye EO, Osman S, Hutchinson OC, et al. The development of [124I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography. Cancer Res. 2002;62:5912–5919
  19. Gitay-Goren H, Cohen T, Tessler S, Soker S, Gengrinovitch S, Rockwell P, et al. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J Biol Chem. 1996;271:5519–5523
  20. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem. 1994;269:26988–26995
  21. Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci U S A. 1991;88:9026–9030
  22. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. 1990;5:519–524
  23. Peters KG, De Vries C, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci U S A. 1993;90:8915–8919
  24. Millauer B, Wizigmann-Voos S, Schnürch H, Martinez R, Møller NP, Risau W, et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 1993;72:835–846
  25. Eckelman EC, Mathis CA. Targeting proteins in vivo: in vitro guidelines. Nucl Med Biol. 2006;33:161–164
  26. Li S, Peck-Radosavljevic M, Kienast O, Preitfellner J, Hamilton G, Kurtaran A, et al. Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy. Ann Oncol. 2003;14:1274–1277
  27. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 1995;55:3964–3968
  28. Laird AD, Christensen JG, Li G, Carver J, Smith K, Xin X, et al. SU6668 inhibits Flk-1/KDR and PDGFβ in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice. FASEB J. 2002;16:681–690
  29. Yang DJ, Kim KD, Schechter NR, Yu DF, Wu P, Azhdarinia A, et al. Assessment of antiangiogenic effect using 99mTc-EC-endostatin. Cancer Biother Radiopharm. 2002;17:233–245
  30. Lee KH, Song SH, Paik JY, Byun SS, Lee SY, Choe YS, et al. Specific endothelial binding and tumor uptake of radiolabeled angiostatin. Eur J Nucl Med Mol Imaging. 2003;30:1032–1037
  31. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–967
  32. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221–228
  33. Sun BF, Kobayashi H, Le N, Yoo TM, Drumm D, Paik CH, et al. Effects of insulinlike growth factor binding proteins on insulinlike growth factor-I biodistribution in tumor-bearing nude mice. J Nucl Med. 2000;41:318–326

PII: S0969-8051(06)00159-4

doi: 10.1016/j.nucmedbio.2006.08.006

Nuclear Medicine and Biology
Volume 33, Issue 8 , Pages 963-969 , November 2006

Article Tools

* Image Usage & Resolution